Price T Rowe Associates Inc Chembio Diagnostics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.66 - $1.23 $10,032 - $18,696
-15,200 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$2.88 - $5.64 $86,181 - $168,771
-29,924 Reduced 66.32%
15,200 $45,000
Q1 2021

May 17, 2021
BUY
$3.4 - $7.97 $22,171 - $51,972
6,521 Added 16.89%
45,124 $158,000
Q4 2020

Feb 16, 2021
BUY
$4.11 - $7.51 $158,658 - $289,908
38,603 New
38,603 $183,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email